Trosolwg o'r swydd

The Children and Young People’s Diabetes Service is well established and is one of the largest in the UK, using the latest diabetes technologies including hybrid closed loop insulin delivery systems. The service provides intensive support for young people struggling with their diabetes. This is an award-winning service with outstanding results. 

We would particularly value applicants with a holistic, team-working perspective who is driven to work in a high performing team and strives to continually improve care. The appointee may have an additional interest that complements the current skills within our team, including mental health and eating disorders, safeguarding, neurodevelopment, research and adolescent medicine. There is a possible future  on-call for diabetes. We provide a busy paediatric and adolescent endocrine service for local residents, those from London and the South East and tertiary and quaternary adolescent referrals. The service also incorporates endocrine liaison clinics for the NHS England specialist services for Children and Young People with Gender Incongruence (once GIDS).

We expect the appointee to have or develop a sub-speciality interest in endocrinology that complements the current interests within our department, and to support the endocrine component of the NHS England specialist services for Children and Young People (CYP) with Gender Incongruence (previously GIDS)

Prif ddyletswyddau'r swydd

The postholder will demonstrate the ability to meet UCLH’s Trust values, having a can-do approach to working with colleagues and being able to see patients as people. They will exhibit leadership skills and have a commitment to clinical governance and ensuring top quality patient care. UCLH diabetes team delivers consultant-led care with each family seeing the same consultant at each quarterly MDT review. Each consultant has overall clinical responsibility for their own patient cohort. The post holder will be participating in teaching activities on the UCLH site and will be responsible for educational supervision of trainees; developing skills in the areas of professional post-graduate teaching, training and supervision, and participating in and delivering annual appraisals. They will provide professional and clinical supervision of endocrine junior doctors and assist in the management of their workloads. They will also liaise with the Education and Training lead for Paediatric Endocrinology colleagues at Great Ormond Street Hospital to support pain (GOSH) to create a comprehensive teaching programme that fulfils the RCPCH Training Curriculum for Paediatric Endocrinology over the two sites.

Gweithio i'n sefydliad

University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research. We provide first-class acute and specialist services across eight sites: ·University College Hospital (incorporating the Elizabeth Garrett Anderson Wing) ·National Hospital for Neurology and Neurosurgery ·Royal National ENT and Eastman Dental Hospitals ·University College Hospital Grafton Way Building ·Royal London Hospital for Integrated Medicine ·University College Hospital Macmillan Cancer Centre ·The Hospital for Tropical Diseases ·University College Hospital at Westmoreland Street We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women’s health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology. We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.